Annandale Capital, LLC Ocuphire Pharma, Inc. Transaction History
Annandale Capital, LLC
- $5.88 Billion
- Q3 2025
A detailed history of Annandale Capital, LLC transactions in Ocuphire Pharma, Inc. stock. As of the latest transaction made, Annandale Capital, LLC holds 10,000 shares of OCUP stock, worth $9,800. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,000Holding current value
$9,800% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding OCUP
# of Institutions
53Shares Held
19.2MCall Options Held
0Put Options Held
0-
Perceptive Advisors LLC New York, NY4.33MShares$4.24 Million0.01% of portfolio
-
Bios Capital Management, LP Fort Worth, TX3.68MShares$3.61 Million7.42% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.35MShares$3.28 Million0.13% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.34MShares$1.32 Million0.0% of portfolio
-
Mink Brook Asset Management LLC West Palm Beach, FL1.24MShares$1.21 Million1.38% of portfolio
About Ocuphire Pharma, Inc.
- Ticker OCUP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 20,579,800
- Market Cap $20.2M
- Description
- Ocuphire Pharma, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of refractive and retinal eye disorders. Its lead product candidate is Nyxol eye drops, a once-daily preservative-free eye drop formulation of phentolamine mesylate, which is in Phase III clinical tr...